Tumors Metastatic to Brain Completed Phase 2 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0029875 (Tumors Metastatic to Brain)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00072163Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to MelanomaTreatment